Category:

Nicole Grassano, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

Laura Joszt, Managing Editor at The American Journal of Managed Care. Welcome to This Week in Managed Care from the Managed Markets News Network

The state of Florida is partnering with the Military Health System to share prescription drug data to help providers in the state combat the risk of prescription drug misuse and abuse among the military population...the MHS prescription drug monitoring program began sharing the prescription drug data and analytics with 39 databases throughout the U.S., with the goal of enabling data-sharing among all 54 PDMPs across the country...Healthcare providers in Florida now have access to controlled substance prescription data from military health providers and facilities...READ MORE

Nicole Grassano, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

Walmart...is moving deeper into the primary care and mental health market, opening a new clinic called Walmart Health in Georgia...Walmart is testing the concept with the initial clinic and will offer primary care, dental, counseling, labs, X-rays and audiology, among other services...READ MORE

Nicole Grassano, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

Laura Joszt, Managing Editor at The American Journal of Managed Care. Welcome to This Week in Managed Care from the Managed Markets News Network

CVS Caremark is saving money on drug costs by kicking specific products with high inflation off their formularies...The pharmacy benefit manager launched its program for “hyperinflation” drug removals in 2017 in which it will take drugs off its template formulary if they have far cheaper equivalents and their high prices aren’t backed by quality metrics...So far, they've identified five drugs to remove as the default option for docs...Through these efforts, Caremark has saved its PBM clients an average of $15 per 30-day supply on drugs—clients on this formulary model paid on average $88.30 for a 30-day drug supply, compared to $102.58 for other formulary designs...As the program is focused on products like that with high costs compared to alternatives, just five have been pulled from formularies so far—leading to a 99% drop in member use...READ MORE

...let’s follow the prescription dollar to expose how specialty pharmacies and covered entities profit from 340B prescriptions...You’ll see the indisputable prescription math that permits large specialty pharmacies to share in the 340B discounts that covered entities earn. These pharmacies’ profits can be $1,000 per prescription—far exceeding their typical profits from dispensing a third-party-paid prescription...No wonder PBMs and specialty pharmacies are racing to become 340B contract pharmacies!...READ MORE

Nicole Grassano, PTNN, Pharmacy Week in Review, this weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.